Literature DB >> 32339614

Pulmonary microbiome patterns correlate with the course of the disease in patients with sepsis-induced ARDS following major abdominal surgery.

Felix C F Schmitt1, Anna Lipinski2, Stefan Hofer3, Florian Uhle2, Christian Nusshag4, Thilo Hackert5, Alexander H Dalpke6, Markus A Weigand2, Thorsten Brenner2, Sébastien Boutin7.   

Abstract

BACKGROUND: Patients with sepsis-induced Acute Respiratory Distress Syndrome (ARDS) are hallmarked by high mortality rates. Early, targeted antibiotic therapy is crucial for patients' survival. The clinical use of a Next Generation Sequencing (NGS)-based approach for pathogen identification may lead to an improved diagnostic performance. Therefore, the objective of this study was to examine changes in the pulmonary-microbiome and resulting influences on patients' outcome in septic ARDS, but also to compare NGS- and culture-based diagnostic methods for pathogen identification.
METHODS: In total, 30 patients in two groups were enrolled in the study: (1) 15 septic ARDS patients following major abdominal surgery and (2) 15 patients undergoing oesophageal resection serving as controls. In the ARDS group, blood samples were collected at ARDS onset as well as 5 days and 10 days afterwards. At the same timepoints, bronchoalveolar lavages (BAL) were performed to collect epithelial lining fluid for culture-, as well as NGS-based analyses and to evaluate longitudinal changes in the pulmonary microbiome. In the control group, only one BAL and one blood sample were collected.
RESULTS: ARDS patients showed a significantly reduced α-diversity (p=0.007**) and an increased dominance (p=0.012*) in their pulmonary-microbiome. The α-diversity-index correlated with the length of stay in the intensive care unit (p-value=0.015) and the need for mechanical ventilation (p-value=0.009). In 42.9% of all ARDS patients, culture-based results were negative, while NGS findings indicated bacterial colonization.
CONCLUSION: Sepsis-induced ARDS is associated with a significant dysbiosis of patients' pulmonary-microbiome, which is closely correlated with the clinical course of the disease. TRIAL REGISTRATION: This prospective, observational pilot study was approved by the Ethics Committee of the Medical Faculty of Heidelberg (trial code no. S-063/2015) and was prospectively registered in the German clinical trials register (DRKS-ID: DRKS00008317 prospectively registered: 28.10.2015). All study patients or their legal representatives signed written informed consent.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  16S RNA gene sequencing; acute respiratory distress syndrome; anti-infective therapy; inflammation; lung; microbiome; sepsis

Year:  2020        PMID: 32339614     DOI: 10.1016/j.jhin.2020.04.028

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

Review 1.  Emerging therapeutic targets for sepsis.

Authors:  Elizabeth W Tindal; Brandon E Armstead; Sean F Monaghan; Daithi S Heffernan; Alfred Ayala
Journal:  Expert Opin Ther Targets       Date:  2021-04-12       Impact factor: 6.902

Review 2.  Gut-Lung Crosstalk in Sepsis-Induced Acute Lung Injury.

Authors:  Xin Zhou; Youxia Liao
Journal:  Front Microbiol       Date:  2021-12-23       Impact factor: 5.640

3.  A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis.

Authors:  Marisa I Metzger; Simon Y Graeber; Mirjam Stahl; Olaf Sommerburg; Marcus A Mall; Alexander H Dalpke; Sébastien Boutin
Journal:  Front Cell Infect Microbiol       Date:  2021-12-06       Impact factor: 5.293

Review 4.  Traditional Chinese Medicine: A promising strategy to regulate inflammation, intestinal disorders and impaired immune function due to sepsis.

Authors:  Xu-Hua Wang; Ding-Qiao Xu; Yan-Yan Chen; Shi-Jun Yue; Rui-Jia Fu; Lu Huang; Yu-Ping Tang
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

5.  Dexmedetomidine Attenuates LPS-Induced Monocyte-Endothelial Adherence via Inhibiting Cx43/PKC-α/NOX2/ROS Signaling Pathway in Monocytes.

Authors:  Yunfei Chai; Zhongming Cao; Runying Yu; Yong Liu; Dongdong Yuan; Liming Lei
Journal:  Oxid Med Cell Longev       Date:  2020-07-19       Impact factor: 6.543

6.  Adipose-derived mesenchymal stem cells attenuate acute lung injury and improve the gut microbiota in septic rats.

Authors:  Junyi Sun; Xianfei Ding; Shaohua Liu; Xiaoguang Duan; Huoyan Liang; Tongwen Sun
Journal:  Stem Cell Res Ther       Date:  2020-09-07       Impact factor: 6.832

7.  Postoperative Complications Are Associated with Long-Term Changes in the Gut Microbiota Following Colorectal Cancer Surgery.

Authors:  Felix C F Schmitt; Martin Schneider; William Mathejczyk; Markus A Weigand; Jane C Figueiredo; Christopher I Li; David Shibata; Erin M Siegel; Adetunji T Toriola; Cornelia M Ulrich; Alexis B Ulrich; Sébastien Boutin; Biljana Gigic
Journal:  Life (Basel)       Date:  2021-03-16

Review 8.  Lung Microbiome in Critically Ill Patients.

Authors:  Mélanie Fromentin; Jean-Damien Ricard; Damien Roux
Journal:  Life (Basel)       Date:  2021-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.